First-in-Human Clinical Application of the Medyria TrackCath System in Endovascular Repair of Complex Aortic Aneurysms (ACCESS Trial): A Prospective Multicenter Single-Arm Clinical Trial.
Nikolaos FlorosTilo KölbelNikolaos TsilimparisAlexander OberhuberDaniel KindlJohannes KalderDrosos KotelisAndrej SchmidtDaniela BranzanDaniela AdolfHubert SchelzigMarkus Udo WagenhäuserPublished in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2021)
The ACCESS Trial suggests that BFV measurement allows for reliable target orifice identification and catheterization. The use of MedTCC is safe and generates short fluoroscopy time and low contrast agent use, which in turn might facilitate complex endovascular procedures.
Keyphrases
- clinical trial
- phase ii
- phase iii
- study protocol
- aortic dissection
- double blind
- open label
- endothelial cells
- magnetic resonance
- randomized controlled trial
- left ventricular
- sensitive detection
- fluorescent probe
- placebo controlled
- magnetic resonance imaging
- pulmonary artery
- cross sectional
- pluripotent stem cells
- induced pluripotent stem cells
- ultrasound guided
- living cells
- heart failure